| Psychological risk factors may moderate pharmacological treatment effects among ischemic heart disease patients. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. | |
| | |
MedLine Citation:
|
PMID: 10593636 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Numerous research findings support the proposed connection between such psychological characteristics as stress and hostility and the manifestation of disease. However, less evidence is available concerning the role(s) psychological factors might play in the process of disease recovery. METHODS: Eighty patients with known coronary disease and exercise-induced ischemia underwent treadmill exercise testing and 48-hour ambulatory electrocardiographic monitoring and completed a battery of standardized psychological tests assessing hostility, depression, and daily stress on four occasions during a 12-week pharmacological treatment study. After withdrawal of antiischemic drugs at baseline, patients returned for subsequent tests at 3-week intervals. During the second and third intervals, patients were prescribed one of two antiischemic medications, atenolol or amlodipine, or given a placebo. All patients were then placed on a combination treatment protocol for the 3 weeks before the final testing date. RESULTS: The combination treatment produced highly significant benefits across all measured cardiac variables (20.3% improvement in exercise performance, 13% reduction in reported angina, 64.0% reduction in the frequency of ischemic episodes; for all, p < .01). However, results showed that high baseline levels of daily stress were associated with reliably smaller treatment effects on measures of ischemia frequency and treadmill exercise time and with a significantly greater likelihood of reporting angina after treatment (r = -0.24, -0.25, and -0.33, respectively; p <.05). In addition, high baseline hostility predicted significantly smaller diastolic blood pressure improvements (r = -0.29, p < .05). CONCLUSIONS: These results indicate that psychological risk factors may have globally negative effects on the course of treatment and suggest particular factors that may warrant attention in trials targeting cardiac symptom reduction. |
| | |
Authors:
|
T Rutledge; W Linden; R F Davies |
Related Documents
:
|
121456 - Glyceryl trinitrate ointment in angina pectoris. 8682006 - Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy? 320856 - Quantitative evaluation of vitamin e in the treatment of angina pectoris. 3069466 - Labetalol in the treatment of stable exertional angina pectoris: a comparison with nife... 15561546 - Fatigue in the elderly population. 18614956 - Effect of resistance training on blood oxidative stress in parkinson disease. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Psychosomatic medicine Volume: 61 ISSN: 0033-3174 ISO Abbreviation: Psychosom Med Publication Date: 1999 Nov-Dec |
Date Detail:
|
Created Date: 2000-01-06 Completed Date: 2000-01-06 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0376505 Medline TA: Psychosom Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 834-41 Citation Subset: IM |
Affiliation:
|
Department of Psychology, University of British Columbia, Vancouver, Canada. dr.tom@musclemail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use* Amlodipine / therapeutic use* Angina Pectoris / drug therapy, psychology Atenolol / therapeutic use* Calcium Channel Blockers / therapeutic use* Depression / complications Double-Blind Method Drug Therapy, Combination Electrocardiography, Ambulatory Exercise Test Female Hostility Humans Male Middle Aged Myocardial Ischemia / drug therapy*, psychology* Prospective Studies Psychiatric Status Rating Scales Regression Analysis Stress, Psychological / complications* Type A Personality* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 29122-68-7/Atenolol; 88150-42-9/Amlodipine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Association between burnout at work and leukocyte adhesiveness/aggregation.
Next Document: Do episodes of anger trigger myocardial infarction? A case-crossover analysis in the Stockholm Heart...